Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma - Quiz - MDSpire

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.

June 24, 2026

UCI Health

Share

Original Source(s)

UCI Health

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

June 24, 2026

Related Content

Frontiers In Oncology

Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review

Baptist Health South Florida

Updated ASTRO Guideline Reflects a New Era for Radiation Therapy in Pancreatic Cancer

An updated clinical practice guideline from the American Society for Radiation Oncology substantially expands and modernizes recommendations for the use of radiation therapy in pancreatic cancer.

by
August 14, 2026
6 min

Jama Network Open

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

Original Source(s)

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

Related Content

Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review

Updated ASTRO Guideline Reflects a New Era for Radiation Therapy in Pancreatic Cancer

National Cancer Institute–Supported Obesity and Cancer Research, 2015-2022